Phase 2 Study of TXA127 in Post-ischemic Stroke Patients

Conditions: Ischemic Stroke Interventions: Drug: talfirastide; Drug: Placebo Sponsors: Constant Therapeutics LLC Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials